⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5014323 | 0.93 | — | — | |
| SCHEMBL6009076 | 0.93 | — | — | |
| SCHEMBL28954685 | 0.84 | — | — | |
| SCHEMBL29205740 | 0.84 | — | — | |
| SCHEMBL291375 | 0.84 | — | — | |
| SCHEMBL28255148 | 0.77 | — | — | |
| SCHEMBL28194540 | 0.77 | — | — | |
| SCHEMBL28250436 | 0.77 | — | — | |
| SCHEMBL28220334 | 0.77 | — | — | |
| SCHEMBL284250 | 0.76 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9255030-B2 | Concentration-modulated coatings | CARDINAL CG COMPANY (US) | 2016-02-09 | — | — | US | disclosed |
| US-20070138000-A1 | CONCENTRATION-MODULATED COATINGS | CARDINAL CG COMPANY (US) | 2007-06-21 | — | — | US | disclosed |
| US-7192647-B2 | Concentration-modulated coatings | CARDINAL CG COMPANY (US) | 2007-03-20 | — | — | US | disclosed |
| US-20050026002-A1 | Concentration-modulated coatings | CARDINAL CG COMPANY | 2005-02-03 | — | — | US | disclosed |